Francesco Carubbi, MD, PhD — Top 1% Arthritis

Francesco Carubbi, MD, PhD is an expert in Rheumatology at San Salvatore Hospital (Italy). As of October 2026, ScienceLeadR ranks Francesco Carubbi in the top 1% of experts worldwide for Arthritis. Francesco Carubbi has authored 244 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 654 (community average: 125). How the SLR is computed.

Rheumatology

Subspecialties: Internal Medicine - Immunology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on October 24, 2026

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2013 - 2026

Source: PubMed

University of L'Aquila

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 244

Citations

Citations: 6 277 1st author: 32 Last author: 14 Unique author: 0

Main journals

Ann Rheum Dis 46

Clin Exp Rheumatol 25

Rheumatology (Oxford) 11

Autoimmun Rev 10

Front Med (Lausanne) 10

Best Journals

Nat Rev Rheumatol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title	Journal	Year	Citations
Association between canakinumab dose and long-term remission in Still's disease: insights from the AIDA network registry. PMID 42639233 — registries, probability, arthritis, precision medicine, therapeutics, biological therapy	Front Pharmacol	2026	0
Dry eye disease in axial spondyloarthritis: heterogeneous ocular surface dysfunction involving tear film instability and tear production from the AIDA network registry. PMID 42609628 — registries, tears, eye diseases, dry eye syndromes, axial spondyloarthritis	Front Med (Lausanne)	2026	0
Pain and its relationship with fatigue in Sjögren disease: an Italian single-centre experience. PMID 42368600 — pain, fatigue	EULAR Rheumatol Open	2025	0
Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry. PMID 42364377 — registries, glucocorticoids, arthritis, rheumatic diseases, therapeutics	Semin Arthritis Rheum	2026	1
Long-term outcomes and prognosis of mixed cryoglobulinemia: a European multicenter study of 1,294 patients. PMID 42316808 — lymphoma, cryoglobulinemia, rheumatic diseases, diagnosis, prognosis	Rheumatology (Oxford)	2026	0